{"id":"W4396810251","doi":"10.2147/jaa.s452386","title":"Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma","year":2024,"lang":"en","type":"article","venue":"Journal of Asthma and Allergy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Sanofi Genzyme; Incyte; Mylan; Baxalta; AstraZeneca; CSL Behring; Regeneron Pharmaceuticals; Merz Pharmaceuticals; Teva Pharmaceutical Industries; Genentech; Grifols; Valeant Pharmaceuticals International; Sanofi; Horizon Pharma; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Asthma; Quality of life (healthcare); Family medicine; Internal medicine; Nursing","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002016176,0.0001740773,0.0004234201,0.0001687552,0.00005238794,0.00003269552,0.00005637012,0.00008070352,0.0001249367],"category_scores_gemma":[0.00005861302,0.00009559444,0.00009835071,0.0002010201,0.0001337226,0.0002301726,0.00002117129,0.0001704026,0.000001648271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003734673,"about_ca_system_score_gemma":0.000224044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003854296,"about_ca_topic_score_gemma":0.00004876795,"domain_scores_codex":[0.9986232,0.00009426748,0.0005328526,0.0001713579,0.0004181518,0.00016017],"domain_scores_gemma":[0.9987582,0.00005390063,0.0004244833,0.0001076829,0.000414356,0.0002414046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004433454,0.0005988933,0.9660432,0.0003387064,0.0006450819,0.0002084377,0.0002034553,0.00003810196,0.0008123578,0.00008786227,0.0004398793,0.02615062],"study_design_scores_gemma":[0.003140078,0.004943644,0.9865613,0.0004565597,0.00003989115,0.00003478639,0.0002131549,0.00002531307,0.0002630056,0.00001489543,0.004174421,0.0001329349],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981189,0.0008247885,0.00007864459,0.00008979187,0.00009395844,0.000158841,0.00002886434,0.00001439851,0.0005918254],"genre_scores_gemma":[0.9992507,0.00009357001,0.0001107605,0.000167772,0.0002158226,0.000002379374,0.00002746652,0.00001803799,0.0001135095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02601768,"threshold_uncertainty_score":0.3898228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01204427778414292,"score_gpt":0.2540729100576127,"score_spread":0.2420286322734698,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}